-
Jun 14, 2022, 5:47 pm291 ptsMugglehead
The biopharmaceutical company Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) says it is looking into the medicinal potential of the psychedelic Dimethyltryptamine (DMT) and its ability to treat anxiety. The Canadian firm announced on Tuesday that it reached an agreement with Entheon Biomedical Corp. (CSE:…
NewsBudz is your go-to app for daily cannabis news, covering everything from medical marijuana breakthroughs to recreational cannabis trends and legalization updates.
Our platform aggregates content from over 30 top-tier cannabis news outlets to deliver a curated stream of the latest headlines, insights, and developments across the marijuana and hemp industries.
Whether you're interested in policy reform, health research, cannabis business, CBD, delta 9 products or lifestyle stories, NewsBudz keeps you informed and connected. Accessible on the web and mobile, NewsBudz makes it easy to explore, read, and share cannabis news anytime, anywhere.